Insider Transactions in Q4 2021 at Utah Medical Products Inc (UTMD)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2021
|
Paul O Richins Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
62
+0.27%
|
$3,100
$50.72 P/Share
|
|
Nov 24
2021
|
Ernst G Hoyer Director |
SELL
Open market or private sale
|
Indirect |
4,900
-49.49%
|
$617,400
$126.41 P/Share
|
|
Nov 23
2021
|
Ernst G Hoyer Director |
SELL
Open market or private sale
|
Indirect |
100
-1.0%
|
$12,500
$125.01 P/Share
|
|
Nov 22
2021
|
Kevin L Cornwell Chairman, CEO, Secretary |
SELL
Bona fide gift
|
Indirect |
2,000
-1.05%
|
$248,000
$124.75 P/Share
|
|
Nov 18
2021
|
Barbara A Payne Director |
SELL
Open market or private sale
|
Direct |
1,249
-13.74%
|
$138,639
$111.06 P/Share
|
|
Nov 17
2021
|
Barbara A Payne Director |
SELL
Open market or private sale
|
Direct |
751
-7.63%
|
$83,361
$111.06 P/Share
|
|
Oct 27
2021
|
Brian Koopman Principal Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
749
+31.74%
|
$39,697
$53.84 P/Share
|
|
Oct 27
2021
|
Brian Koopman Principal Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-71.33%
|
$42,867
$99.62 P/Share
|